Clinical trial Recruiting at 2 sites Interventional Ages 35 Weeks to 42 Weeks

Monitoring vital signs of newborns using advanced wireless sensors

Official title: Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT06693817 · Data updated 2026-11-12

This study is testing a new wireless sensor to see if it can safely and accurately monitor the vital signs of healthy newborns during their first two hours after birth compared to the traditional wired system.

More Parents trials

Quick facts

Study typeInterventional
Ages35 Weeks to 42 Weeks
SexAll
Enrollment600 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations5 sites (Londrina, Paraná and 4 other locations)
StatusRecruiting
StartedApril 8, 2025
Main results expectedJuly 30, 2027
Study endsDecember 30, 2027
Registry record updatedMay 8, 2026
Trial IDNCT06693817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are newborns who are at least 35 weeks gestational age and clinically stable at delivery.

Probably not a fit

Patients who may not benefit from this study include those born before 35 weeks gestational age or those who are not clinically stable at delivery.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the feasibility, safety, and accuracy of a new wireless skin sensor system for monitoring vital signs in healthy newborns (≥ 35 weeks gestational age) during the first two hours after delivery. The study will compare the wireless monitoring system to the standard wired system while the newborns are under unsupervised parental care in the obstetrical center. Both monitoring systems will be placed on the infants' chest and limb to continuously track heart rate, oxygen saturation, and skin temperature. The goal is to improve neonatal care and reduce the risk of Sudden Unexpected Postnatal Collapse (SUPC).

Why it matters

Potential benefit: If successful, this study could enhance the safety and monitoring of newborns immediately after birth, potentially reducing the incidence of neonatal complications.

How similar studies have gone: While the use of wireless monitoring technology is gaining traction, this specific approach to monitor vital signs in newborns immediately after delivery is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Newborns ≥35 weeks (gestational age)
2. Newborns determined to be clinically stable at delivery
3. Newborns with no skin abnormalities

Exclusion criteria:

1. Newborns ≤ 35 weeks (gestational age)
2. Newborns determined to not be clinically stable at delivery
3. Newborns with Skin abnormalities

Where it's running

  • Montreal Children's Hospital
    Montreal, Quebec, Canada
    Recruiting
  • Royal Victoria Hospital
    Montreal, Quebec, Canada
    Recruiting
  • Hospital Universitário da Universidade Estadual de Londrina
    Londrina, Paraná, Brazil
    Not yet recruiting
  • Nuovo Ospedale degli Infermi
    Ponderano, Bi, Italy
    Not yet recruiting
  • Lucerne Cantonal Hospital
    Lucerne, Canton of Lucerne, Switzerland
    Not yet recruiting

Study contacts

  • Principal investigator: Guilherme Sant'Anna, MD, PhD — The Research institute of the McGill University Health Centre
  • Study coordinator: Guilherme Sant´Anna, MD, PhD
  • Email: guilherme.santanna@mcgill.ca
  • Phone: 514-934-1934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.